कृपया अन्य खोज का प्रयास करें
Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Ximluci, a ranibizumab biosimilar used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults. Its pre-clinical phase products include BIIB801, a biosimilar candidate for the treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, and axial spondylitis; Xdivane for skin cancer, lung cancer, renal cell cancer, head and neck cancer, and bladder and urinary tract cancer; Xtrudane for brain cancer, melanoma, lung cancer, kidney cell cancer, head and neck cancer, and bladder and urinary tract cancer; and Xdarzane for multiple melanoma. Xbrane Biopharma AB (publ) was incorporated in 2008 and is headquartered in Solna, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David Drew | - | - | Member of Scientific Advisory Board |
Gunnar Von Heijne | - | - | Member of Scientific Advisory Board |
Joen Luirink | - | - | Member of Scientific Advisory Board |
Karin Wingstrand | 64 | 2015 | Independent Director |
Anders Lennart Tullgren | 60 | 2018 | Independent Chairman of the Board |
Peter Edman | 67 | 2015 | Independent Director |
Eva Nilsagard | 57 | 2019 | Independent Director |
Björn Olof Nilsson | 65 | - | Member of Scientific Advisory Board |
Samuel Wagner | - | 2008 | Co-Founder & Member of Scientific Advisory Board |
Mats Thoren | 51 | 2020 | Independent Director |
Ivan Cohen-Tanugi | 61 | 2019 | Independent Director |
Kirsti Gjellan | - | 2022 | Independent Director |
Kirsti Gjellan | 60 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है